Fondazione Piemonte l'Oncologia-Istituto Ricerca Cura Cancro

Candiolo, Torino 10060

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Breast Cancer, Pancreatic Cancer, Soft Tissue Sarcoma

Studies at this site

• A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma — Completed
• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer — Completed
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling